These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12907532)

  • 1. A multicenter study of the effect of solution temperature on nasal potential difference measurements.
    Boyle MP; Diener-West M; Milgram L; Knowles M; Foy C; Zeitlin P; Standaert T;
    Chest; 2003 Aug; 124(2):482-9. PubMed ID: 12907532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of perfusate temperature on nasal potential difference.
    Bronsveld I; Vermeulen F; Sands D; Leal T; Leonard A; Melotti P; Yaakov Y; de Nooijer R; De Boeck K; Sermet I; Wilschanski M; Middleton PG;
    Eur Respir J; 2013 Aug; 42(2):389-93. PubMed ID: 23100510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the variability of nasal potential difference, a biomarker of CFTR activity.
    Kyrilli S; Henry T; Wilschanski M; Fajac I; Davies JC; Jais JP; Sermet-Gaudelus I
    J Cyst Fibros; 2020 Jul; 19(4):620-626. PubMed ID: 31699569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium.
    Middleton PG; Geddes DM; Alton EW
    Eur Respir J; 1994 Nov; 7(11):2050-6. PubMed ID: 7875281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of airway ion transport assists the diagnosis of cystic fibrosis.
    Middleton PG; House HH
    Pediatr Pulmonol; 2010 Aug; 45(8):789-95. PubMed ID: 20597077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects.
    Smith SN; Middleton PG; Chadwick S; Jaffe A; Bush KA; Rolleston S; Farley R; Delaney SJ; Wainwright B; Geddes DM; Alton EW
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):129-34. PubMed ID: 9870926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased contact time improves adenovirus-mediated CFTR gene transfer to nasal epithelium of CF mice.
    Jiang C; Akita GY; Colledge WH; Ratcliff RA; Evans MJ; Hehir KM; St George JA; Wadsworth SC; Cheng SH
    Hum Gene Ther; 1997 Apr; 8(6):671-80. PubMed ID: 9113507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between nasal potential difference measurements, genotype and clinical condition in patients with cystic fibrosis.
    Ho LP; Samways JM; Porteous DJ; Dorin JR; Carothers A; Greening AP; Innes JA
    Eur Respir J; 1997 Sep; 10(9):2018-22. PubMed ID: 9311495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transepithelial nasal potential difference (NPD) measurements in cystic fibrosis (CF).
    Sands D
    Med Wieku Rozwoj; 2013; 17(1):13-7. PubMed ID: 23749691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of different chloride and glucose solutions on nasal potential difference.
    House HH; Middleton PG
    Pediatr Pulmonol; 2009 Jul; 44(7):645-8. PubMed ID: 19514053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal potential difference in congenital bilateral absence of the vas deferens.
    Pradal U; Castellani C; Delmarco A; Mastella G
    Am J Respir Crit Care Med; 1998 Sep; 158(3):896-901. PubMed ID: 9731023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I trial of intranasal Moli1901 for cystic fibrosis.
    Zeitlin PL; Boyle MP; Guggino WB; Molina L
    Chest; 2004 Jan; 125(1):143-9. PubMed ID: 14718433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of nasal potential difference in mild asthmatics.
    Chung NC; Illek B; Widdicombe JH; Fischer H
    Chest; 2003 May; 123(5):1467-71. PubMed ID: 12740262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis.
    Knowles MR; Paradiso AM; Boucher RC
    Hum Gene Ther; 1995 Apr; 6(4):445-55. PubMed ID: 7542031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Airway surface liquid calcium modulates chloride permeability in the cystic fibrosis airway.
    Middleton PG; Pollard KA; Donohoo E; Wheatley JR; Geddes DM; Alton EW
    Am J Respir Crit Care Med; 2003 Nov; 168(10):1223-6. PubMed ID: 12947027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased nasal potential difference and amiloride sensitivity in neonates with cystic fibrosis.
    Gowen CW; Lawson EE; Gingras-Leatherman J; Gatzy JT; Boucher RC; Knowles MR
    J Pediatr; 1986 Apr; 108(4):517-21. PubMed ID: 3958823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified technique for measurement of nasal transepithelial potential difference in infants.
    Southern KW; Noone PG; Bosworth DG; Legrys VA; Knowles MR; Barker PM
    J Pediatr; 2001 Sep; 139(3):353-8. PubMed ID: 11562613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modified method to measure nasal potential difference.
    Leal T; Lebacq J; Lebecque P; Cumps J; Wallemacq P
    Clin Chem Lab Med; 2003 Jan; 41(1):61-7. PubMed ID: 12636051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal apical cell membrane in cystic fibrosis respiratory epithelium. An in vitro electrophysiologic analysis.
    Cotton CU; Stutts MJ; Knowles MR; Gatzy JT; Boucher RC
    J Clin Invest; 1987 Jan; 79(1):80-5. PubMed ID: 3793933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.